These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35325897)

  • 1. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
    Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
    Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Oncological Therapy and
    Oei SL; Thronicke A; Kröz M; von Trott P; Schad F; Matthes H
    Integr Cancer Ther; 2020; 19():1534735420917211. PubMed ID: 32478590
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of Combined Targeted and Helixor
    Schad F; Thronicke A
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.
    Schad F; Thronicke A; Steele ML; Merkle A; Matthes B; Grah C; Matthes H
    PLoS One; 2018; 13(8):e0203058. PubMed ID: 30148853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: a real-world data study.
    Schad F; Steinmann D; Oei SL; Thronicke A; Grah C
    Radiat Oncol; 2023 Mar; 18(1):47. PubMed ID: 36879290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.
    Axtner J; Steele M; Kröz M; Spahn G; Matthes H; Schad F
    BMC Cancer; 2016 Aug; 16():579. PubMed ID: 27485618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall Survival of Nonmetastasized NSCLC Patients Treated With Add-On
    Thronicke A; Matthes B; von Trott P; Schad F; Grah C
    Integr Cancer Ther; 2020; 19():1534735420940384. PubMed ID: 32856476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
    Thronicke A; Steele ML; Grah C; Matthes B; Schad F
    BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and Safety of Viscum album L Applications in Cancer Patients With Preexisting Autoimmune Diseases: Findings From the Network Oncology Study.
    Oei SL; Thronicke A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2019; 18():1534735419832367. PubMed ID: 30808274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
    Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
    Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
    Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
    Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
    Krüerke D; Schenker M; Matter-Walstra K
    BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
    Schad F; Axtner J; Kröz M; Matthes H; Steele ML
    Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients.
    Thronicke A; Reinhold T; von Trott P; Grah C; Matthes B; Matthes H; Schad F
    PLoS One; 2020; 15(7):e0236426. PubMed ID: 32716969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
    Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
    BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
    Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
    J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
    Melzer J; Iten F; Hostanska K; Saller R
    Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.